Rucaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor used as an anti-cancer medication to treat recurrent ovarian, fallopian tube, and peritoneal cancers. Pharmaceutical laboratories utilize this… Read more
![Chemical structure of 5,5'-(((Methylazanediyl)bis(methylene))bis(4,1-phenylene))bis(8-fluoro-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F55-Methylazanediylbismethylenebis41-phenylenebis8-fluoro-2346-tetrahydro-1H-azepino543-cdindol-1-one.png&w=3840&q=75)
![Chemical structure of 8-Fluoro-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1408282-26-7-8-Fluoro-2346-tetrahydro-1H-azepino543-cdindol-1-one.png&w=3840&q=75)
![Chemical structure of 8-Fluoro-5-(4-((hydroxy(methyl)amino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2306161-16-8-8-Fluoro-5-4-hydroxymethylaminomethylphenyl-2346-tetrahydro-1H-azepino543-cdindol-1-one.png&w=3840&q=75)





![Chemical structure of N-(4-(8-Fluoro-1-oxo-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-5-yl)benzyl)-N-methylnitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-8-Fluoro-1-oxo-2346-tetrahydro-1H-azepino543-cdindol-5-ylbenzyl-N-methylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-(4-(8-Fluoro-6-nitroso-1-oxo-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-5-yl)benzyl)-N-methylnitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-8-Fluoro-6-nitroso-1-oxo-2346-tetrahydro-1H-azepino543-cdindol-5-ylbenzyl-N-methylnitrous-amide.png&w=3840&q=75)







Rucaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor used as an anti-cancer medication to treat recurrent ovarian, fallopian tube, and peritoneal cancers. Pharmaceutical laboratories utilize this category of high-quality reference standards, including impurities, metabolites, and stable isotope-labelled compounds, to support rigorous analytical testing and quality control processes. These materials are essential for accurate impurity profiling and method validation throughout the drug development lifecycle. Stable isotope-labelled compounds serve as internal standards for precise quantification in mass spectrometry, while related process impurities and degradation products assist in characterization and monitoring during stability studies. By providing access to these critical analytical tools, researchers can ensure compliance with regulatory standards and maintain the safety and efficacy of the drug substance.